UDP-galactopyranose mutase has a novel structure and mechanism

D A Sanders1, A G Staines, S A McMahon

  • 1The Centre for Biomolecular Sciences, The University, St. Andrews, Scotland KY16 9ST, UK.

Nature Structural Biology
|September 27, 2001
PubMed

Insights

UDP-galactopyranose mutase (mutase) is essential for pathogens like Mycobacterium tuberculosis and is a potential therapeutic target. This study reveals its structure and suggests a mechanism involving transient substrate reduction.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Microbiology

Background:

  • Uridine diphosphogalactofuranose (UDP-Galf) is crucial for bacterial and parasitic cell walls, including pathogens like Mycobacterium tuberculosis.
  • UDP-galactopyranose mutase (mutase) synthesizes UDP-Galf from UDP-galactopyranose (UDP-Galp).
  • Mutase is essential for mycobacterial viability and absent in humans, presenting a therapeutic target.

Purpose of the Study:

  • To elucidate the structural basis and catalytic mechanism of UDP-galactopyranose mutase.
  • To investigate the role of the flavin cofactor in mutase activity.
  • To provide insights for the development of novel anti-infective agents.

Main Methods:

  • X-ray crystallography to determine the 3D structure of E. coli mutase at 2.4 A resolution.
  • Site-directed mutagenesis to identify active site residues.
  • Enzyme activity assays to assess the role of flavin reduction.

Main Results:

  • The crystal structure revealed a novel cleft containing conserved residues and the flavin adenine dinucleotide (FAD) cofactor.
  • Site-directed mutagenesis confirmed the active site location within this cleft, with substrate proximity to FAD.
  • Enzyme activity was dependent on the reduced state of the flavin cofactor.

Conclusions:

  • UDP-galactopyranose mutase likely functions via transient reduction of its substrate.
  • The structural and mechanistic insights advance our understanding of essential microbial pathways.
  • This research supports the development of mutase inhibitors as potential therapeutics against pathogens.

Related Concept Videos

Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
Biosynthesis of Polysaccharides01:26

Biosynthesis of Polysaccharides

Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
Peptidoglycan Synthesis01:28

Peptidoglycan Synthesis

Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan biosynthesis begins in...